Does the development of new medicinal products in the European Union address global and regional health concerns?
<p>Abstract</p> <p>Background</p> <p>Since 1995, approval for many new medicinal products has been obtained through a centralized procedure in the European Union. In recent years, the use of summary measures of population health has become widespread. We investigated wh...
Main Authors: | Álvarez-Martín Elena, García-Altés, Anna, Catalá-López, Ferrán, Gènova-Maleras Ricard, Morant-Ginestar Consuelo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-12-01
|
Series: | Population Health Metrics |
Online Access: | http://www.pophealthmetrics.com/content/8/1/34 |
Similar Items
-
Correlación de la financiación de la investigación sanitaria en el ámbito del Sistema Nacional de Salud con la carga de enfermedad de la población española
by: Ferrán Catalá López, et al.
Published: (2009-01-01) -
LOS ESTUDIOS DE CARGA DE ENFERMEDAD EN EL ESTABLECIMIENTO DE PRIORIDADES EN SALUD: RÉPLICA
by: Ferrán Catalá López, et al.
Published: (2009-01-01) -
Burden of disease and economic evaluation of healthcare interventions: are we investigating what really matters?
by: Gènova-Maleras Ricard, et al.
Published: (2011-04-01) -
Estimación de la carga de enfermedad en España
en el año 2000
by: Ricard Génova Maleras, et al.
Published: (2005-01-01) -
Burden of disease due to cancer in Spain
by: Pérez-Gómez Beatriz, et al.
Published: (2009-01-01)